|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 484.83 USD | +1.28% |
|
+0.31% | +6.94% |
| 06/08 | Rothschild & Co Redburn Adjusts Vertex Pharmaceuticals Price Target to $580 From $570 | MT |
| 05/08 | Vertex Pharmaceuticals Seen Well Positioned Ahead of Pipeline Catalysts, UBS Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 123B | |||||
| 1,043B | |||||
| 621B | |||||
| 435B | |||||
| 361B | |||||
| 293B |
Select your edition
All financial news and data tailored to specific country editions
